Proto Labs, Inc. Logo

Proto Labs, Inc.

0KRR.L

(0.0)
Stock Price

29,84 USD

-21.68% ROA

2.51% ROE

-8.69x PER

Market Cap.

9.789.146,00 USD

0% DER

0% Yield

3.42% NPM

Proto Labs, Inc. Stock Analysis

Proto Labs, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Proto Labs, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Proto Labs, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Proto Labs, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Proto Labs, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Proto Labs, Inc. Revenue
Year Revenue Growth
2012 125.991.000
2013 163.112.000 22.76%
2014 209.583.000 22.17%
2015 264.106.000 20.64%
2016 298.055.000 11.39%
2017 344.490.000 13.48%
2018 445.596.000 22.69%
2019 458.728.000 2.86%
2020 434.395.000 -5.6%
2021 488.098.000 11%
2022 488.398.000 0.06%
2023 522.820.000 6.58%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Proto Labs, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2012 9.137.000
2013 11.863.000 22.98%
2014 16.607.000 28.57%
2015 18.350.000 9.5%
2016 22.388.000 18.04%
2017 23.560.000 4.97%
2018 28.735.000 18.01%
2019 32.692.000 12.1%
2020 36.940.000 11.5%
2021 44.241.000 16.5%
2022 38.222.000 -15.75%
2023 40.420.000 5.44%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Proto Labs, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 13.957.000
2013 16.154.000 13.6%
2014 22.122.000 26.98%
2015 29.716.000 25.56%
2016 36.651.000 18.92%
2017 41.200.000 11.04%
2018 52.513.000 21.54%
2019 49.766.000 -5.52%
2020 51.742.000 3.82%
2021 69.186.000 25.21%
2022 67.544.000 -2.43%
2023 68.232.000 1.01%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Proto Labs, Inc. EBITDA
Year EBITDA Growth
2012 41.026.000
2013 58.868.000 30.31%
2014 71.666.000 17.86%
2015 81.275.000 11.82%
2016 79.252.000 -2.55%
2017 90.700.000 12.62%
2018 115.652.000 21.58%
2019 110.720.000 -4.45%
2020 92.430.000 -19.79%
2021 67.577.000 -36.78%
2022 66.372.000 -1.82%
2023 79.068.000 16.06%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Proto Labs, Inc. Gross Profit
Year Gross Profit Growth
2012 76.138.000
2013 101.702.000 25.14%
2014 128.401.000 20.79%
2015 154.403.000 16.84%
2016 166.937.000 7.51%
2017 193.842.000 13.88%
2018 238.679.000 18.79%
2019 235.290.000 -1.44%
2020 217.827.000 -8.02%
2021 222.691.001 2.18%
2022 215.465.000 -3.35%
2023 237.128.000 9.14%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Proto Labs, Inc. Net Profit
Year Net Profit Growth
2012 24.025.000
2013 35.277.000 31.9%
2014 41.635.000 15.27%
2015 46.514.000 10.49%
2016 42.707.000 -8.91%
2017 51.778.000 17.52%
2018 76.588.000 32.39%
2019 63.655.000 -20.32%
2020 50.867.000 -25.14%
2021 33.372.000 -52.42%
2022 -103.462.000 132.26%
2023 31.816.000 425.19%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Proto Labs, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 1
2013 1 100%
2014 2 0%
2015 2 0%
2016 2 0%
2017 2 0%
2018 3 50%
2019 2 0%
2020 2 -100%
2021 1 0%
2022 -4 133.33%
2023 1 400%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Proto Labs, Inc. Free Cashflow
Year Free Cashflow Growth
2012 8.278.000
2013 29.688.000 72.12%
2014 13.703.000 -116.65%
2015 19.734.000 30.56%
2016 43.883.000 55.03%
2017 49.113.001 10.65%
2018 35.825.000 -37.09%
2019 53.822.000 33.44%
2020 59.959.000 10.24%
2021 21.033.000 -185.07%
2022 40.393.000 47.93%
2023 21.073.000 -91.68%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Proto Labs, Inc. Operating Cashflow
Year Operating Cashflow Growth
2012 25.675.000
2013 48.441.000 47%
2014 57.210.000 15.33%
2015 64.096.000 10.74%
2016 77.499.000 17.29%
2017 81.748.000 5.2%
2018 122.929.000 33.5%
2019 116.052.000 -5.93%
2020 106.969.000 -8.49%
2021 55.242.000 -93.64%
2022 62.079.000 11.01%
2023 24.179.000 -156.75%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Proto Labs, Inc. Capital Expenditure
Year Capital Expenditure Growth
2012 17.397.000
2013 18.753.000 7.23%
2014 43.507.000 56.9%
2015 44.362.000 1.93%
2016 33.616.000 -31.97%
2017 32.634.999 -3.01%
2018 87.104.000 62.53%
2019 62.230.000 -39.97%
2020 47.010.000 -32.38%
2021 34.209.000 -37.42%
2022 21.686.000 -57.75%
2023 3.106.000 -598.2%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Proto Labs, Inc. Equity
Year Equity Growth
2012 156.699.000
2013 211.643.000 25.96%
2014 265.539.000 20.3%
2015 327.645.000 18.96%
2016 379.833.000 13.74%
2017 461.215.000 17.65%
2018 541.497.000 14.83%
2019 585.790.000 7.56%
2020 644.356.000 9.09%
2021 828.493.000 22.23%
2022 697.648.000 -18.76%
2023 684.922.000 -1.86%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Proto Labs, Inc. Assets
Year Assets Growth
2012 172.722.000
2013 230.175.000 24.96%
2014 287.031.000 19.81%
2015 361.036.000 20.5%
2016 414.241.000 12.84%
2017 518.738.000 20.14%
2018 618.985.000 16.2%
2019 673.667.000 8.12%
2020 744.204.000 9.48%
2021 928.582.000 19.86%
2022 802.168.000 -15.76%
2023 784.245.000 -2.29%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Proto Labs, Inc. Liabilities
Year Liabilities Growth
2012 16.023.000
2013 18.532.000 13.54%
2014 21.492.000 13.77%
2015 33.391.000 35.64%
2016 23.427.000 -42.53%
2017 43.755.000 46.46%
2018 77.488.000 43.53%
2019 87.877.000 11.82%
2020 99.848.000 11.99%
2021 100.089.000 0.24%
2022 104.520.000 4.24%
2023 99.323.000 -5.23%

Proto Labs, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
19
Net Income per Share
-4.03
Price to Earning Ratio
-8.69x
Price To Sales Ratio
0.02x
POCF Ratio
13.69
PFCF Ratio
0.19
Price to Book Ratio
1.33
EV to Sales
-0.15
EV Over EBITDA
-1.25
EV to Operating CashFlow
-1.11
EV to FreeCashFlow
-1.44
Earnings Yield
-0.12
FreeCashFlow Yield
5.25
Market Cap
0,01 Bil.
Enterprise Value
-0,07 Bil.
Graham Number
48.84
Graham NetNet
2.65

Income Statement Metrics

Net Income per Share
-4.03
Income Quality
-0.63
ROE
-0.15
Return On Assets
0.02
Return On Capital Employed
0.04
Net Income per EBT
0.62
EBT Per Ebit
0.98
Ebit per Revenue
0.06
Effective Tax Rate
0.38

Margins

Sales, General, & Administrative to Revenue
0.14
Research & Developement to Revenue
0.08
Stock Based Compensation to Revenue
0.03
Gross Profit Margin
0.44
Operating Profit Margin
0.06
Pretax Profit Margin
0.06
Net Profit Margin
0.03

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
2.56
Free CashFlow per Share
1.97
Capex to Operating CashFlow
-0.23
Capex to Revenue
-0.03
Capex to Depreciation
-0.4
Return on Invested Capital
0.03
Return on Tangible Assets
-0.22
Days Sales Outstanding
57.87
Days Payables Outstanding
23.39
Days of Inventory on Hand
18.02
Receivables Turnover
6.31
Payables Turnover
15.6
Inventory Turnover
20.26
Capex per Share
-0.58

Balance Sheet

Cash per Share
3,95
Book Value per Share
26,32
Tangible Book Value per Share
14.77
Shareholders Equity per Share
26.32
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-1.41
Current Ratio
2.74
Tangible Asset Value
0,38 Bil.
Net Current Asset Value
0,11 Bil.
Invested Capital
0
Working Capital
0,13 Bil.
Intangibles to Total Assets
0.38
Average Receivables
0,08 Bil.
Average Payables
0,02 Bil.
Average Inventory
14057000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Proto Labs, Inc. Dividends
Year Dividends Growth
2022 0

Proto Labs, Inc. Profile

About Proto Labs, Inc.

Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end markets. The company was incorporated in 1999 and is headquartered in Maple Plain, Minnesota.

CEO
Dr. Robert Bodor
Employee
2.415
Address
5540 Pioneer Creek Drive
Maple Plain, 55359

Proto Labs, Inc. Executives & BODs

Proto Labs, Inc. Executives & BODs
# Name Age
1 Dr. Robert Bodor
President, Chief Executive Officer & Director
70
2 Ms. Agnes Semington
Chief Human Resources Officer
70
3 Jason Frankman
Controller & Secretary
70
4 Mr. Daniel Schumacher
Chief Financial Officer
70
5 Mr. Oleg Ryaboy
Global Chief Technology Officer
70
6 Mr. Bjoern Klaas
Vice President, GM and MD of Europe, Middle East & Africa
70
7 Mr. Brian F. Peters
Chief Marketing Officer
70
8 Mr. Bram de Zwart
Head of Innovation of Hubs
70
9 Ms. Alex Cappy
Vice President & Chief Executive Officer of Hubs
70

Proto Labs, Inc. Competitors